None listed
Conditions
Interventions
None listed
Sponsors
The Catholic University of Korea, Seoul St. Mary's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: ? 55 years old or older and 85 years old or older ? Subjects who agreed to participate in this study ? Those who can participate in all the tests (comprehensive neuropsychological test, brain MRI, blood test) performed when participating in this study ? Satisfying mild cognitive impairment according to NIA-AA (National Institute on Aging-Alzheimer's Association) diagnostic criteria through structured interview with a psychiatrist. ? Clinical Dementia Rating (CDR): 0.5 points
Exclusion criteria
Exclusion criteria: ? Those diagnosed with the following neurological diseases cannot participate in this study. · Major neurodegenerative diseases such as Parkinson's disease and Huntington's disease · Brain lesions accompanied by neurological disorders: brain tumor, progressive supranuclear palsy Convulsive disorders that can cause Generalized Tonic-Clonic Seizures (GTCS) Brain diseases that can cause secondary dementia, such as carbon monoxide poisoning or alcoholic dementia ? Those who have a history of abuse or dependence on alcohol or drugs within the past 2 years at the time of clinical research registration ? Those with medical conditions that can cause mental abnormalities - thyroid, liver disease, kidney disease, etc. The evaluation of the subject's disease is based on the medical judgment of the investigator · Except for cases that may significantly interfere with neuropsychological evaluation due to the use of drugs such as antidepressants, antipsychotics, antianxiety drugs, or sedatives and sedatives according to the medical judgment of a specialist ? When other investigators judge that it is inappropriate to participate in clinical research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sub-domain scores of neuropsychological assessment battery; Total score of neuropsychological assessment battery; Parameter of brain thickness and volume; Parameter of brain function | — |
Secondary
| Measure | Time frame |
|---|---|
| Amyloid and tau pathology test using blood sample; blood inflammatory marker | — |
Countries
Korea, Republic of
Contacts
Public ContactDONG WOO KANG
The Catholic University of Korea, Seoul St. Mary's Hospital
Outcome results
None listed